Drugs / Mature dendritic cell vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00683670 | Aug 2008 → Jun 2016 | melanoma | University of Pennsylvania | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Mature dendritic cell vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00683670 ↗ |
| Modality | Vaccine | “dendritic cells (a kind of white blood cell) as a vaccine” NCT00683670 ↗ |
| Route | Intravenous | “The DC vaccine will be given intravenously every three weeks” NCT00683670 ↗ |